UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Guardian Pharmacy Services
GRDN
$2.61B
| $301K | ﹤0.01% |
+11,491
| New | +$274K |
2025 Q3
0 quarters
|
|
2202
Power Solutions International
PSIX
$1.15B
| $295K | ﹤0.01% |
+3,000
| New | +$266K |
2025 Q3
0 quarters
|
|
2203
Universal Logistics Holdings
ULH
$457M
| $294K | ﹤0.01% |
12,543
-4,082
| -25% | -$103K |
2024 Q1
6 quarters
|
|
2204
Granite Ridge Resources
GRNT
$629M
| $290K | ﹤0.01% |
53,591
-53,144
| -50% | -$290K |
2023 Q4
7 quarters
|
|
2205
Chegg
CHGG
$81.7M
| $283K | ﹤0.01% |
187,643
| – | – |
2015 Q1
42 quarters
|
|
2206
Cullinan Oncology
CGEM
$999M
| $280K | ﹤0.01% |
47,163
-59,417
| -56% | -$435K |
2024 Q2
5 quarters
|
|
2207
Oric Pharmaceuticals
ORIC
$1.24B
| $279K | ﹤0.01% |
+23,235
| New | +$244K |
2025 Q3
0 quarters
|
|
2208
Niagen Bioscience
NAGE
$213M
| $273K | ﹤0.01% |
29,282
+140
| +0.5% | +$1.41K |
2025 Q2
1 quarter
|
|
2209
Westrock Coffee
WEST
$799M
| $272K | ﹤0.01% |
55,894
-19,589
| -26% | -$118K |
2024 Q2
5 quarters
|
|
2210
Corsair Gaming
CRSR
$1.47B
| $267K | ﹤0.01% |
29,912
-67,413
| -69% | -$607K |
2022 Q1
14 quarters
|
|
2211
Aeva Technologies
AEVA
$952M
| $267K | ﹤0.01% |
+18,400
| New | +$349K |
2025 Q3
0 quarters
|
|
2212
eToro Group
ETOR
$2.06B
| $256K | ﹤0.01% |
+6,200
| New | +$319K |
2025 Q3
0 quarters
|
|
2213
OrthoPediatrics
KIDS
$565M
| $247K | ﹤0.01% |
13,348
-18,525
| -58% | -$382K |
2024 Q2
5 quarters
|
|
2214
Weyerhaeuser
WY
$13.8B
| $243K | ﹤0.01% |
9,790
-6,054,385
| -100% | -$155M |
2013 Q2
49 quarters
|
|
2215
HBT Financial
HBT
$1.27B
| $233K | ﹤0.01% |
9,265
-14,494
| -61% | -$372K |
2024 Q2
5 quarters
|
|
2216
CMB.TECH NV
CMBT
$5.98B
| $233K | ﹤0.01% |
24,793
+19,005
| +328% | +$174K |
2025 Q1
2 quarters
|
|
2217
ZTO Express
ZTO
$15.1B
| $230K | ﹤0.01% |
11,971
| – | – |
2025 Q2
1 quarter
|
|
2218
Vipshop
VIPS
$6.13B
| $229K | ﹤0.01% |
11,667
-3,500,419
| -100% | -$58.1M |
2014 Q1
46 quarters
|
|
2219
Altisource Portfolio Solutions SA Net Settle Stakeholder Warrants
ASPSW
$8.1M
| $215K | ﹤0.01% |
307,671
| – | – |
2025 Q2
1 quarter
|
|
2220
iShares MSCI China ETF
MCHI
$6.01B
| $213K | ﹤0.01% |
3,232
-462
| -13% | -$27.7K |
2025 Q2
1 quarter
|
|
2221
Latham Group
SWIM
$711M
| $206K | ﹤0.01% |
27,092
-45,957
| -63% | -$338K |
2024 Q4
3 quarters
|
|
2222
ArriVent BioPharma
AVBP
$825M
| $202K | ﹤0.01% |
10,962
-18,593
| -63% | -$365K |
2025 Q2
1 quarter
|
|
2223
LSB Industries
LXU
$706M
| $185K | ﹤0.01% |
+23,529
| New | +$191K |
2025 Q3
0 quarters
|
|
2224
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$371M
| $185K | ﹤0.01% |
+3,203
| New | +$182K |
2025 Q3
0 quarters
|
|
|
2225
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$5.3M
| $178K | ﹤0.01% |
307,671
| – | – |
2025 Q2
1 quarter
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.